Log in to save to my catalogue

Synthesis, [sup.123]I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-B...

Synthesis, [sup.123]I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-B...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A760515737

Synthesis, [sup.123]I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

About this item

Full title

Synthesis, [sup.123]I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

Publisher

MDPI AG

Journal title

International journal of molecular sciences, 2023-07, Vol.24 (15)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Prostate-specific membrane antigen (PSMA) has been identified as a target for the development of theranostic agents. In our current work, we describe the design and synthesis of novel N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-L-lysine (DCL) urea-based PSMA inhibitors with a chlorine-substituted aromatic fragment at the lysine ε-nitrogen atom, a...

Alternative Titles

Full title

Synthesis, [sup.123]I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A760515737

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A760515737

Other Identifiers

ISSN

1422-0067

DOI

10.3390/ijms241512206

How to access this item